> Welcome to community Information > Cancer Care Technologies > Technology in Surgery and Therapy > Index: All Articles
Diagnosis and Treatment Options > Surgery for Prostate Cancer > Radiotherapy for Prostate Cancer > Prostate Brachytherapy > Nuclear Medicine Prostate Therapy > Electroporation for Prostate Cancer – Early Clinical Trials
Dr Lyn Oliver AM MSc PhD
Retired Medical Physicist
Cancer Incidence and Treatment Cure Rates
Prostate cancer is one of the most common forms of cancer. There are different treatment methods and there are advantages and disadvantages for each treatment option. However, the cure rates for each of the treatment options are similar.
The cure rate in early prostate cancer of surgery or radiation therapy is in the range of 95% for all prostate cancer cases. But, as well as having the high cure rate, there are possible complications in the different modes of treatment that the patient needs to consider before proceeding.
Medical specialists in urology, radiation oncology and medical oncology can advise you during this early consultation period. The choice you need to discuss with them is whether it’s a case of no treatment with your doctor monitoring your medical condition or having to choose one of the treatment methods:
- chemotherapy or other forms of pharmaceutical treatment;
- surgery;
- radiation therapy;
- brachytherapy; or
- a prostate ablation technique.
Cancer Australia has summarised the prostate cancer statistics using data from the Australian Institute of Health and Welfare (AIHW):
AIHW stated:
- In 2018, it is estimated that the age–standardised incidence rate will be 119 cases per 100,000 males.
- The incidence rate of prostate cancer among males is expected to increase from age group 35–39 until age group 65–69. It is then expected to decrease until age group 80–84 before increasing for males aged 85+.
- In 2018, it is estimated that the age–standardised mortality rate will be 25 deaths per 100,000 males. The age-standardised mortality rate from prostate cancer is expected to increase with age from age group 50–54.
The salient statistics are:
The 2020 expected Australian NEW prostate cancer cases = 16,741 men
The estimated number of deaths from prostate cancer in 2018 = 3,152 men
Estimated % of all male deaths from cancer in 2020 =12.0%
The %ge of all new cancers for prostate cancer = 22%
5 year survival (2012 – 16) of all prostate cancer cases = 95%
Males living with prostate cancer = 89,703
Take Home Message
The chances of any person being diagnosed with any form of cancer during their lifetime is approximately 1 in 4.
The Australian Institute of Health and Welfare estimated that Australian men have a lifetime chance of 1 in 7 for prostate cancer. Older men should be aware of the prostate cancer incidence and should ensure that they have regular checks.
Early detection of cancer is important to ensure good management of your health and establish the best outcome based on your health details discussed with your doctor.
For those who are diagnosed with having prostate cancer, and a form of treatment is advised, each of the major treatment options will offer roughly the same 5-year survival of 95%.
It is important that the cancer patient decides on the most appropriate form of treatment, taking into account all the pros and cons, by speaking to both a radiation oncologist and a urologist to help decide which is the best treatment option. Each of these prostate treatment modes rely heavily on modern technology.
——————————————————-————————–
References
Cancer Australia
https://prostate-cancer.canceraustralia.gov.au/statistics
Australian Institute of Health and Welfare
http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129545133
http://www.aihw.gov.au/cancer/prostate/
https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/survival-rates.html
Lyn Oliver, 7 May 2018
—————————————————————————————————-
> Welcome to community Information > Cancer Care Technologies > Technology in Surgery and Therapy > Index: All Articles
0 Comments